EPCLUSA-VELPANAT

Shubham Pharmaceuticals
EPCLUSA-VELPANAT

Product Code : 56

 

Product Description

EPCLUSA :

Epclusa contains a combination of Sofosbuvir and Velpatasvir. EPCLUSA has been innovated by GILEAD SCIENCE,INC

 

USAGE & DISCRIPTION :

Epclusa is used to treat chronic hepatitis C in adults with HCV genotype 1, 2, 3, 4, 5, or 6.

 

BRAND NAME

EPCLUSA

ACTIVE INGREDIENTS

SOFOSBUVIR + VELPATASVIR

PACKING

1*28

DOSES FORM

TABLETS (IN PLASTIC BOTTLE)

STRENGTH

400 MG + 100 MG

MFG BY

GILEAD SCIENCE ,INC

 

CLINICAL APPLICATIONS :

EPCLUSA had high overall cure rates of 99% for GT2 patients  and 95% for GT3 patients. EPCLUSA was also found to be highly effective in patients with GT1, GT4, GT5and GT6, with overall cure rates ranging from 97-100%. Epclusa is given in combination with another antiviral medicine called ribavirin in people who also have advancedcirrhosis.

 

STORAGE :

Storage between 15C and 30C.

 

VELPANAT is genric version of EPCLUSA. Both contain same Drug / molecule Sofosbuvir and velpatasvir.

 

VELPANAT :

It contains Drug / Molecules called Sofosbuvir and Velpatasvir

VELPANAT is generic version of EPCLUSA.

 

USAGE & DISCRIPTION :

Velpanat is used to treat chronic hepatitis C in adults with HCV genotype 1, 2, 3, 4, 5, or 6.

 

BRAND NAME

VELPANAT

INTERNATIONAL BRAND NAME

EPCLUSA

ACTIVE INGREDIENTS

SOFOSBUVIR + VELPATASVIR

PACKING

1*28

DOSES FORM

TABLETS (IN PLASTIC BOTTLE)

STRENGTH

400 MG + 100 MG

MFG BY

NATCO PHARMA LIMITED. (INDIA)

 

CLINICAL APPLICATIONS :

VELPANAT had high overall cure rates of 99% for GT2 patients and 95% for GT3 patients.VELPANAT was also found to be highly effective in patients with GT1, GT4, GT5 and GT6, with overall cure rates ranging from 97-100%. VELPANAT is given in combination with another antiviral medicine called ribavirin in people who also have advanced cirrhosis.

 

STORAGE :

Storage between 15C and 30C.

 

 

Trade Information

  • Main Export Market(s)
  • Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia